Kamada (KMDA) Cash & Equivalents (2012 - 2026)

Kamada (KMDA) posted quarterly Cash & Equivalents of $32.9 million for Q1 2026, down 56.82% year-on-year from $76.2 million in Q1 2025, and down 56.38% on a QoQ basis from $75.5 million in Q4 2025.

Kamada (KMDA) Cash & Equivalents (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Cash & Equivalents for 15 consecutive years, with $32.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Equivalents fell 56.82% year-over-year to $32.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.9 million (down 56.82% YoY) and the FY2025 annual result came in at $75.5 million, down 3.78% from the prior year.
  • Cash & Equivalents retreated to $32.9 million in Q1 2026 per KMDA's latest filing, from $75.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for KMDA reached as high as $31.3 billion in Q3 2022 and fell as low as $29933.0 in Q2 2022.
  • A 5-year average of $1.9 billion and a median of $55.6 million in 2023 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 99.96% — and 2023, when it jumped 72689.23%.
  • Year by year, Cash & Equivalents stood at $34.3 million in 2022, then jumped by 62.42% to $55.6 million in 2023, then jumped by 40.97% to $78.4 million in 2024, then fell by 3.78% to $75.5 million in 2025, then sank by 56.38% to $32.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $32.9 million, $75.5 million, and $72.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.28 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 32.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.92 Mn
Dec 31, 2025 75.47 Mn
Sep 30, 2025 72.00 Mn
Jun 30, 2025 65.99 Mn
Mar 31, 2025 76.25 Mn
Dec 31, 2024 78.44 Mn
Sep 30, 2024 72.00 Mn
Jun 30, 2024 56.55 Mn
Mar 31, 2024 48.19 Mn
Dec 31, 2023 55.64 Mn
Sep 30, 2023 52.60 Mn
Jun 30, 2023 21.79 Mn
Mar 31, 2023 27.12 Mn
Dec 31, 2022 34.26 Mn
Sep 30, 2022 31.25 Bn
Jun 30, 2022 29,933.00
Mar 31, 2022 21.97 Mn
Dec 31, 2021 18.59 Mn
Sep 30, 2021 99.84 Mn
Jun 30, 2021 68.42 Mn